Merck (WBO:MRK) FFO


WBO:MRK Merck & Co Inc WBO:MRK
71 GF Score
Price €114.36
GF Value €105.26
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck FFO?

FFO (Funds from operations) only applies to REITs.

WBO:MRK
71GF Score
Merck & Co Inc WBO:MRK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (WBO:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of €114.36 is trading 8.6% above its estimated GF Value™ of €105.26. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for WBO:MRK:

  • FFO:
  • GF Value™: €105.26 vs. price of €114.36 (8.6% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the WBO:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
71GF Score

Get the complete analysis for WBO:MRK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€114.36
Price
€105.26
GF Value